Concurrent Investment Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8M Buy
98,862
+16,661
+20% +$5.06M 0.36% 51
2026
Q1
$17.6M Buy
82,201
+4,466
+6% +$999K 0.19% 119
2025
Q4
$13.3M Buy
77,735
+62,062
+396% +$9.65M 0.15% 141
2025
Q3
$2.1M Sell
15,673
-417
-3% -$44.2K 0.04% 456
2025
Q2
$1.57M Buy
16,090
+361
+2% +$28.6K 0.03% 492
2025
Q1
$1.14M Buy
15,729
+5,448
+53% +$429K 0.03% 506
2024
Q4
$743K Buy
+10,281
New +$780K 0.02% 567
2024
Q3
– Sell
-9,910
Closed -$1.05M – 1123
2024
Q2
$1.05M Buy
9,910
+1,320
+15% +$127K 0.03% 417
2024
Q1
$834K Buy
8,590
+870
+11% +$76.5K 0.03% 413
2023
Q4
$605K Buy
+7,720
New +$526K 0.03% 452

Other funds holding LRCX

Concurrent Investment Advisors's LRCX Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Lam Research (LRCX) stake by 20% in Q2 2026, buying an estimated $5.06M and bringing the position to 98,862 shares worth $42.8M. The position accounts for 0.36% of the portfolio, ranked #51.

Concurrent Investment Advisors first reported a position in LRCX in Q4 2023 and has held it in 10 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Concurrent Investment Advisors held 98,862 shares of Lam Research worth $42.8M as of Q2 2026.
  • Concurrent Investment Advisors bought 16,661 Lam Research shares in Q2 2026, an estimated $5.06M.
  • Lam Research made up 0.36% of Concurrent Investment Advisors's portfolio in Q2 2026, its #51 holding.
  • Concurrent Investment Advisors first reported a position in Lam Research in Q4 2023 and has held it in 10 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.